Selected references

  1. Arushanian EB. [Comparative evaluation of epiphyseal melatonin and benzodiazepine anxiolytics]. Eksp.Klin.Farmakol. 2012;75(3):35-40.
  2. Boyko Y, Ording H, and Jennum P. Sleep disturbances in critically ill patients in ICU: how much do we know? Acta Anaesthesiol.Scand. 2012;56(8):950-958.
  3. Dijk DJ, Duffy JF, Silva EJ, et al. Amplitude reduction and phase shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure in humans. PLoS.One. 2012;7(2):e30037.
  4. Etain B, Dumaine A, Bellivier F, et al. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum.Mol.Genet. 9-15-2012;21(18):4030-4037.
  5. Forbes-Robertson S, Dudley E, Vadgama P, et al. Circadian disruption and remedial interventions: effects and interventions for jet lag for athletic peak performance. Sports Med. 3-1-2012;42(3):185-208.
  6. Gitto E, Aversa S, Salpietro CD, et al. Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J.Pineal Res. 2012;52(3):291-295.
  7. Gonciarz M, Gonciarz Z, Bielanski W, et al. The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study. J.Physiol Pharmacol. 2012;63(1):35-40.
  8. Morganti P, Fabrizi G, Palombo P, et al. New chitin complexes and their anti-aging activity from inside out. J.Nutr.Health Aging 2012;16(3):242-245.
  9. Moura LM, Bezerra JM, and Fleming NR. Treatment of hemicrania continua: case series and literature review. Rev.Bras.Anestesiol. 2012;62(2):173-187.
  10. Munoz F, Lopez-Pena M, Mino N, et al. Topical application of melatonin and growth hormone accelerates bone healing around dental implants in dogs. Clin.Implant.Dent.Relat Res. 2012;14(2):226-235.
  11. Nikles J, Lo V, Giam JA, et al. Exploring melatonin prescribing among customers of compounding pharmacies in Australia. Med.J.Aust. 4-2-2012;196(6):384-385.
  12. Otmani S, Metzger D, Guichard N, et al. Effects of prolonged-release melatonin and zolpidem on postural stability in older adults. Hum.Psychopharmacol. 2012;27(3):270-276.
  13. Sekeroglu MR, Huyut Z, and Him A. The susceptibility of erythrocytes to oxidation during storage of blood: effects of melatonin and propofol. Clin.Biochem. 2012;45(4-5):315-319.
  14. Sigurdardottir LG, Valdimarsdottir UA, Fall K, et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol.Biomarkers Prev. 2012;21(7):1002-1011.
  15. Soares SR, Martinez-Varea A, Hidalgo-Mora JJ, et al. Pharmacologic therapies in endometriosis: a systematic review. Fertil.Steril. 2012;98(3):529-555.

This evidence-based monograph was prepared by The Natural Standard Research Collaboration